1. Home
  2. EW vs NDAQ Comparison

EW vs NDAQ Comparison

Compare EW & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

SELL

Current Price

$86.37

Market Cap

49.1B

Sector

Health Care

ML Signal

SELL

Logo Nasdaq Inc.

NDAQ

Nasdaq Inc.

SELL

Current Price

$93.27

Market Cap

54.9B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
EW
NDAQ
Founded
1958
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.1B
54.9B
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
EW
NDAQ
Price
$86.37
$93.27
Analyst Decision
Buy
Buy
Analyst Count
29
18
Target Price
$101.81
★ $108.75
AVG Volume (30 Days)
★ 3.4M
2.8M
Earning Date
11-04-2026
10-22-2026
Dividend Yield
N/A
★ 1.33%
EPS Growth
N/A
★ 60.10
EPS
1.07
★ 1.80
Revenue
★ $6,067,600,000.00
$4,277,000,000.00
Revenue This Year
$11.45
$12.46
Revenue Next Year
$9.93
$8.38
P/E Ratio
$82.36
★ $51.97
Revenue Growth
★ 11.55
7.87
52 Week Low
$74.43
$76.55
52 Week High
$96.29
$101.79

Technical Indicators

Market Signals
Indicator
EW
NDAQ
Relative Strength Index (RSI) 48.45 50.01
Support Level $82.05 $87.63
Resistance Level $89.41 $93.34
Average True Range (ATR) 2.07 1.67
MACD 0.20 0.19
Stochastic Oscillator 65.50 67.39

Price Performance

Historical Comparison
EW
NDAQ

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.

Share on Social Networks: